1Chandrasekar B,Tanguay J F. Platelets and restenosis[J]. J Am Coll Cardiol, 2000,35 (3): 555.
2Ikeda U, Shimada K. Matrix metalloproteinases and coronary artery diseases[J]. Clin Cardiol,2003,26(2) : 55.
3Furman C, Luo Z, Walsh K,et al. Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery[J]. FEBS Lett, 2002, 531(2) : 122.
4Shah P. Inflammation, metalloproteinases, and increased proteolysis :an emerging pathophysiological paradigm in aortic aneurysm[J]. Circulation, 1997,96(7) :2115.
5Glukhova M A, Kabakov AE, Frid M G,et al. Modulation of human aorta smooth muscle cell phenotype:a study oof muscle specific variants of vinculin,caldsmon and actin expression[J].Proc Natl Acad Sci USA,1998,85(24):9542.
6Wang H, Keiser J A. Expression of membrane-type matrix metalloproteinase in rabbit neointimal tissue and its correlation with matrix-metalloproteinase-2 activation [J]. J Vasc Res,1998,35(1):45.
7Fizgerald M, Hayward I P, Thomas A C, et al. Matrix metalloproteinase can facilitate the heparanase-induced promotion of phenotype change in vascular smooth muscle cells[J]. Atherosclerosis, 1999,145 (1) : 97.
8Johnson C, Galis Z S. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization[J]. Arterioscler Thromb Vase Biol,2004,24(1) :54.
9Mason D P, Kenagy R D, Hasenstab D, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery[J]. Circ Res, 1999,85 (12) : 1179.
10Galis ZS, Khatri J J. Matrix metalloproteinases in vascular remodeling andatherogenesis:the good,the bad,and the ugly[J].Circ Res, 2002,90(3):251.
6Cheng G C, Loree H M, Kamm R D, et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions [J]. Circulation, 1993,87 (4) : 1179.
7Richardson P D, Davies M J, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques[J]. Lancet, 1989, 2(10): 940.
8Galis Z S, Sukhova G K, Lark M W, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnearable region of human atherosclerotic plaques [J]. J Clin Invest, 1994,94(6):2493.
9Galis Z S, Muszynski M, Sukhova G K, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize, a complement of enzymes required for extraccllular matrix digestion[J].Cir Res, 1994,75(1):181.
10Ahsan C H, Shah A, Ezekowitz M, Acute statin treatment in reducing risk after acute coronary syndrome, the MIRACL Trial[J].Curre Opin Cardiol, 2001,16(6):390.
